Primer-probe composition for detecting TNNC1 gene mutation and application thereof
A primer-probe and composition technology, applied in DNA/RNA fragment, recombinant DNA technology, microorganism determination/inspection, etc., can solve the problems of high equipment requirements, high price, cumbersome process, etc., and achieve high sensitivity and low cost , good repeatability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0071] Referring to the 2011 American Heart Association guidelines for the diagnosis of hypertrophic cardiomyopathy, a proband with familial hypertrophic cardiomyopathy clinically diagnosed in the Department of Cardiovascular Medicine, the First Affiliated Hospital of Dali University was obtained (the patient signed an informed consent and passed the Dali University The genome was extracted from the peripheral venous blood (approved by the Medical Ethics Committee), and the pathogenic mutation sites related to the pathogenesis of HCM were found through the whole exome sequencing technology, and a new mutation site related to HCM was found through the comparison and analysis of the sequencing results Point TNNC1, c.19G>C (the 19th base G in the coding region of the gene is mutated to C), this mutation leads to the change of A7P in the amino acid of TNNC1 gene, and the mutation screening method of real-time fluorescent PCR is used for the new mutation site Click to verify.
[00...
Embodiment 2
[0084] This example verifies the sensitivity and specificity of the primer-probe composition of the present invention.
[0085] (1) Sensitivity and repeatability of primer probe composition
[0086] The wild type and mutant type of TNNC1 gene c.19G>C were respectively diluted 10 times as a template, and the primer probe composition of the present invention was used for real-time fluorescent PCR detection (ABI7500 real-time fluorescent PCR instrument). The reaction system is shown in Table 3 As shown, the reaction conditions are as shown in Table 4, and the sensitivity of the primer probe composition was tested.
[0087] table 3
[0088] Reactive components Amount added (μL) PCR reaction solution 5 Rox Calibration Dye 0.1 forward primer 0.5 reverse primer 0.5 wild-type probe 0.5 mutant probe 0.5 template 0.8 pure water 2.1
[0089] Table 4
[0090]
[0091] The result is as Figure 4-Figure 7 As shown, as th...
Embodiment 3
[0103] The present embodiment uses the primer probe composition of the present invention to perform TNNC1, c.19G on 22 patients with hypertrophic cardiomyopathy (known genotypes sequenced by capillary electrophoresis, patients with informed consent, and approved by the Medical Ethics Committee of Dali University) >C mutation detection, using the kit of the present invention to carry out real-time fluorescent PCR reaction as described in Table 3 and Table 4, according to the results of fluorescence signal analysis, wherein, GG genotype: has a higher FAM fluorescence signal, HEX fluorescence signal is lower; GC Genotype: FAM fluorescence signal and HEX fluorescence signal have little difference; CC genotype: has higher HEX fluorescence signal, and FAM fluorescence signal is lower. Such as Figure 12 In the genotyping scatter diagram shown, there were 18 cases of GG genotype, 2 cases of GC genotype, and 2 cases of CC genotype. The detection results were consistent with the result...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


